Stenting and medical therapy for atherosclerotic renal-artery stenosis
Angiotensin II Type 1 Receptor Blockers
Renal Artery Obstruction
Renal-artery stenting did not confer a significant benefit with respect to the prevention of clinical events when added to comprehensive, multifactorial medical therapy in people with atherosclerotic renal-artery stenosis and hypertension or chronic kidney disease. (Funded by the National Heart, Lung and Blood Institute and others; ClinicalTrials.gov number, NCT00081731.).